The Korean Journal of Health Psychology
- KOREAN
- P-ISSN1229-070X
- E-ISSN2713-9581
- KCI
The Effects of Neurofeedback Training on Affective, Behavioral, and Physical Symptoms of Premenstrual Dysphoric Disorder
Abstract
Premenstrual dysphoric disorder(PMDD) is characterized by some combination of marked affective symptoms, which may be accompanied by physical symptoms. The neurofeedback training regulating frontal lobe EEG asymmetry that is vulnerability in women with PMDD had been performed to seek such a treatment in this study by reason that there is no suitable treatment with no side effects until now. Participants had been screened by Shortened Premenstrual Assessment Form, Symptom-Checklist-90-Revision, Daily Rating Form, and interview among 704 unmarried women. In result 18 women took PMDD diagnosis, and then these are assigned each 9 in treatment group and in control group by paired-matches. Premenstrual Assessment Form was used for measuring the effects of neurofeedback training on symptoms of PMDD. After Neurofeedback training, EEG asymmetry scores in treatment group was corrected more than those of the waiting list control group, and affective, behavioral and physical symptoms had been reduced more than control group. It seems that neurofeedback training helps to correct resting EEG of women with PMDD, has directive effects on affective and behavioral, and has mediate effects on physical symptoms of PMDD. In PMDD treatments of clinical practices, neurofeedback training could be a favorite treatment for both clinicians and patients.
- keywords
- Neurofeedback training, EEG biofeedback training, EEG asymmetry, Premenstrual Dysphoric Disorder(PMDD), 뉴로피드백 훈련, EEG 바이오피드백 훈련, EEG 비대칭, 월경 전 불쾌장애(PMDD)
Reference
강현정, 손정락 (1998). 인지행동치료와 이완훈련이 월경전증후군의 감소에 미치는 효과. 한국심리 학회지: 건강, 3(1), 141-155.
고선규, 권정혜 (2004). 월경 전 증후군에 대한 인지행동집단치료 효과. 인지행동치료, 4, 1-10.
김미리혜 (2007). 월경전증후군의 이해와 치료: 인지행동적 접근을 중심으로. 한국심리학회지: 건강. 12(3), 649-666.
박혜연, 안창일 (2004). 월경 전 불쾌증상 집단의 신체감각에 대한 인지 특성: 미혼여성들을 대상으로. 한국심리학회지: 임상, 23(4), 891-903.
윤가현 (1998). 성문화와 심리. 서울: 학지사.
이만홍, 김지웅, 이정현, 김덕만 (2002). 축약형 월경전기 평가서 표준화 연구 및 인터넷상에서의 적용 가능성. 신경정신의학, 41, 159-167.
임성견, 김정호 (2008). 호흡 마음챙김명상이 여대생의 월경전 증후군에 미치는 효과. 한국심리학회 지: 건강, 13(1), 221-236.
지연경 (2005). 뉴로피드백을 통한 전두엽 EEG 비대칭 조절이 정서에 미치는 효과. 고려대학교 대학원 석사학위 청구논문.
최승원 (2007). 전두엽 알파파 뉴로피드백의 우울증 치료효과. 고려대학교 대학원 박사학위 청구논문.
최환석 (2005). 바이오피드백의 임상 적용. 가정의학회지, 26(11), 427-431.
Accortt, E. E., & Allen, J. J. B. (2006). Frontal EEG Asymmetry and Premenstrual Dysphoric Symptomatology. Journal of Abnormal Psychology, 115(1), 179-184.
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision. Washington DC: American Psychiatric Association.
Allen J. J. B., & Harmon-Jones, E. (1997). Behavioral activation sensitivity and resting frontal EEG asymmetry: Covariation of putative indicators related to risk for mood disorders. Journal of Abnormal Psychology, 106(1), 159-163.
Baehr, E., Rosenfeld, J. P., & Baehr, R. (1997). The clinical use of an alpha asymmetry indices in depressed patient vs. normal controls. International Journal of Psychophysiology, 31, 89-92.
Beahr, E., Rosenfeld, J. P., & Beahr, R. (1999). Clinical use of an alpha asymmetry protocol in the treatment of mood disorders. San Diego: Academic Press.
Baehr, E., Rosenfeld, J. P., Baehr, R., & Earnest, C. (1998). Comparison of two EEG asymmetry indices in depressed patients vs. normal controls. International Journal of Psychophysiology, 31, 89-92.
Baehr, E., Rosenfeld, J. P., Miller, L., & Baehr, R. (2004). Premenstrual dysphoric disorder and changes in frontal alpha asymmetry. International Journal of Psychophysiology 52(2), 159-167.
Bronson, P. (2000). Hormone mediated mood disorders in peri-meropausal women. Hilton Head Island, SC: 35th Annual Meeting American Academy of Environmental Medicine.
Coan, J. A., & Allen, J. J. B. (2003). Frontal EEG asymmetry and the behavioral activation and inhibition systems. Psychophysiology, 40, 106-114.
Coan, J. A., & Allen, J. J. B. (2004). Frontal EEG asymmetry as a moderator and mediator of emotion. Biological Psychology, 67(1, 2), 7-50.
Cohen, L. S., Miner, C., Brown, E., Freeman, E. W., Halbreich, U., Sundell, K., & McCray, S. (2002). Premenstrual daily fluoxetine for premenstrual dysphoric disorder: A placebo-controlled, clinical trial using computerized diaries. Obstetrics and Gynecology, 100(3), 435-444.
Dalton, K. (1990). Once a month: The original premenstrual syndrome handbook. Washington: Hunter House.
Davidson, R. J. (1993). Cerebral asymmetry and emotion: Conceptual and methodological conundrums. Cognition and Emotion, 7, 115-138.
Davidson, R. J. (1998a). Affective and affective disorder: Perspectives from affective neuroscience. Congnition and Emotion, 12, 307-330.
Davidson, R. J. (1998b). Anterior electrophysiological asymmetries, emotion and depression: Conceptual and methodologyical conundrums. Psychophysiology, 35, 607-614.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973). The symptom checklist-90: An outpatient psychiatric rating scale-preliminary report. Psychopharmalogical Bulletin, 9, 13-27.
Endicott, J. (2000). History, evolution, and diagnosis of premenstrual dysphoric disorder. Journal of Clinical Psychiatry, 61(12), 5-8.
Endicott, J., Nee, J., Cohen, J., & Halbreich, U. (1986). Premenstrual changes: Patterns and correlates of daily ratings. Journal of Affective Disorder, 10, 127-135.
Eriksson, E., Hedberg, M. A., Andersch, B., & Sundblad, C. (1995). The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of prementrual syndrome. Neuropsychopharmacology, 12, 167-176.
Freeman, E. W., Schweizer, E., Richels, K. (1995). Personality factors in women with premenstrual syndrome. Psychosomatic Medicine, 57, 453-459.
Freeman, E. W., & Sondheimern, S. J. (2003). Premenstrual dysphoric disorder: Recognition and treatment. Journal of Clinical Psychiatry, 5, 30-39.
Freeman, E. W. (2004). Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder. CNS Drugs, 18(7), 453-468.
Gotlib, I. H., & Rosenfeld, J. P. (1998). Frontal EEG alpha asymmetry, depression, and cognitive functioning. Cognition & Emotion, 12(3), 449-478.
Gray, J. A. (1981). A critique of Eysenck's theory personality. Berlin: Springer-Verlag.
Gray, J. A. (1990). Brain systems that mediate both emotion and cognition. Cognition & Emotion, 4, 269-288.
Halbreich, U., Endicott, J., Schacht, S., & Nee, J. (1982). The diversity of premenstrual changes as reflected in the premenstrual assessment form. Acta Psychiatric Scandinavica, 65, 46-65.
Hammond, D. C. (2005). Neurofeedback treatment of depression and anxiety. Journal of Adult Development, 12(2/3), 131-137.
Hartlage, S. A., Arduino, K. E., & Gehlert, S. (2001). Premenstrual dysphoric disorder and risk for major depressive disorder: A preliminary study. Journal of Clinical Psychology, 57(12), 1571-1578.
Hartlage, S. A., & Gehlert, S. (2001). Differentiating premenstrual dysphoric disorder from premenstrual exacerbation of other disorder: A methods dilemma. Clinical Psychology: Science and Practice, 8, 242-253.
Hsiao, M., Hsiao, C., Liu, C. (2004). Premenstrual symptoms and premenstrual excerbation in patients with psychiatric disorder. Psychiatry and Clinical Neurosciences, 58, 186-190.
Jasper, H. H. (1958). The ten-twenty electrode system of the international federation. Electroencephalography and Clinical Neurophysiology, 10, 371-375.
Kornstein, S. G., & Smith, K. C. (2004). Antidepressant treatment of premenstrual syndrome and premenstrual dysphoric disorder. Primary Psychiatry, 11, 53-57.
Ling, F. W. (2000). Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices. Journal of Clinical Psychiatry, 61(12), 9-16.
Oldfield, R. C. (1971). The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia, 9(1), 97-113.
Robbins, J. M., & Kirmayer, L. J. (1991). Attributions of common somatic symptoms. Psychological Medicine, 21(4), 1029-1045.
Roca, C. A., Schmidt, P. J., Bloch, M., Rubinow, D. R. (1996). Implications of endocrine studies of premenstrual syndrome. Annals of General Psychiatry, 26, 576-580.
Rohde, A., & Klemme, A. (2002). Premenstrual dysphoric disorder as the most severe form of the premenstrual syndrome. Geburtsbilfe und Frauenbeilkunde, 62(1), 17-25.
Rosenfeld, J. P., Cha, G., Blair, T., & Gotlib, I. H. (1995). Operant(biofeedback) control of left-right frontal alpha power differences: potential neurotherapy for affective disorders. Biofeedback and Self-regulation, 20, 241-258.
Silber, T. J., & Valadez-Meltzer, A. (2005). Premenstrual dysphoric disorder in adolescents: Case reports of treatment with fluo etine and review of the literature. Journal of Adolescent Health, 37(6), 518-525.
Steiner, M., & Born, L. (2000). Advance in the diagnosis and treatment of premenstrual dysphoric. Central Nervous System Drugs, 13(4), 287-304.
Steiner, M., & Pearlstein, T. (2000). Premenstrual dysphoria and the serotonin system: Pathophysiology and treatment. Journal of Clinical Psychiatry, 61(12), 17-21.
Steiner, M., Pearlstein, T., Cohen, L. S., Endicott, J., Kornstein, S. G., Carla, R., David, R. L., & Yonkers, K. (2006). Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: The role of SSRIs. Journal of Women's Health, 15(1), 57-69.
Sundblad, C., Modigh, K., Andersch, B., Eriksson, E. (1992). Clomipramine effectively reduces premenstrual irritability and dysphoria: A placebo-controlled trial. Acta Psychiatrica Scandinavica, 85, 39-47.
Sutton, S. K., & Davidson, R. J. (2006). A biological substrate of the behavioral approach and inhibition systems. Psychological Science, 8(3), 204-210.
Ursula, A. (2002). Managing PMS & PMDD: Exploring new treatment options. AWHONN Lifelines, 6(5), 430-437.
Winter, E. J., Ashton, D. J., & Moore, D. L. (1991). Dispelling myths: A study of PMS and relationship satisfaction. The Journal for Nurse Practitioners, 16(5), 37-40.
- Downloaded
- Viewed
- 0KCI Citations
- 0WOS Citations